Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer
Breast cancer frequently metastasizes to bone, where it leads to poor clinical prognosis. Due to the peculiarity of the bone microstructure, the uptake of drugs often happens at non-targeted sites, which produces a similar cytotoxicity in both cancerous and healthy cells. In this study, a rational s...
Saved in:
Main Authors: | Xianzhu Ke (Author), Wen Lin (Author), Xiaokang Li (Author), Hailiang Wang (Author), Xin Xiao (Author), Zheng Guo (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
by: Yanjuan Huang, et al.
Published: (2020) -
Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
by: Yue Zhang, et al.
Published: (2017) -
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
by: Meng Lei, et al.
Published: (2019) -
Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer
by: Haiqin Huang, et al.
Published: (2022) -
Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis
by: Zhiwei Zhang, et al.
Published: (2021)